Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $94.36 USD
Change Today +5.16 / 5.78%
Volume 1.4M
INCY On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Reid M. Huber Ph.D.

Chief Scientific Officer and Executive Vice President, Incyte Corporation
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 2 different industries.

See Board Relationships
42--

Background*

Dr. Reid M. Huber, Ph.D. serves as the Chief Scientific Officer and Executive Vice President of Incyte Corporation. Dr. Huber leads drug discovery research primarily in the area of hematology/oncology. He served as Senior Vice President of Discovery Biology at Incyte Corporation. He was a founding member of the team that started drug discovery at Incyte Corporation in 2002. Dr. Huber joined Incyte in January 2002 as an Associate Director of Applied Technology. For nine ...

Read Full Background

Corporate Headquarters*

1801 Augustine Cut-Off
Wilmington, Delaware 19803

United States

Phone: 302-498-6700
Fax: --

Board Members Memberships*

2014-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education*

PhD
Washington University, St. Louis
BS
Murray State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $94.36 USD +5.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
€459.0K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Amr Mamdouh Abdel Majid Chairman of the Board and Managing Director
GlaxoSmithKline S.A.E
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.